Search Results
You are looking at 1 - 9 of 9 items for
- Author: T. R. BROWN x
- Refine by access: All content x
Search for other papers by N. Bagchi in
Google Scholar
PubMed
Search for other papers by T. R. Brown in
Google Scholar
PubMed
ABSTRACT
It has been reported that prior exposure of thyroid tissue to TSH in vitro induces a state of refractoriness to new challenges of the hormone. We have investigated the effect of repeated TSH treatment on thyroid secretion to determine whether such refractoriness exists in vivo. The rate of thyroid secretion was estimated by measuring the rate of hydrolysis of labelled thyroglobulin from mouse thyroid glands in vitro. The thyroid glands were labelled in vivo with 131I and then cultured for 20 h in the presence of mononitrotyrosine, an inhibitor of iodotyrosine deiodinase. The rate of hydrolysis of labelled thyroglobulin was measured as the percentage of radioactivity released as free iodotyrosines and iodothyronines into the gland and the medium at the end of incubation. Thyrotrophin was administered in vivo at hourly intervals for 2–4 injections. The corresponding control group received saline injections every hour except for the last injection when they received TSH. The peak rates of thyroglobulin hydrolysis, measured 2 h following the last injection, were similar in animals receiving two, three or four TSH injections and were not different from those in the control groups. Serum tri-iodothyronine and thyroxine concentrations 2 h after the last injection were higher in the groups receiving multiple TSH injections. Thyroidal cyclic AMP accumulation in response to TSH was markedly depressed in the group receiving multiple injections compared with the group receiving a single injection of TSH in vivo. These data indicate that (1) the stimulatory effect of TSH on thyroidal secretion is not diminished by prior administration of the hormone in vivo, (2) repeated TSH administrations in vivo cause refractoriness of the adenylate cyclase response to TSH and (3) a dichotomy exists between the secretory response and the adenylate cyclase response to repeated administrations of TSH.
J. Endocr. (1985) 106, 153–157
Search for other papers by N. BAGCHI in
Google Scholar
PubMed
Search for other papers by T. R. BROWN in
Google Scholar
PubMed
Search for other papers by B. SHIVERS in
Google Scholar
PubMed
Search for other papers by R. E. MACK in
Google Scholar
PubMed
The rates of thyroglobulin hydrolysis and iodothyronine release from mouse thyroid glands were studied in vitro. Recently iodinated thyroglobulin ('new pool') had been labelled during life by injection of 131I 3 h before removal of the thyroid, 'old pool' thyroglobulin had been labelled by the administration of 125I in the drinking water for 1 week starting 3 weeks earlier. Chromatographic analysis of pronase digests of the thyroid glands showed that the iodothyronine content of the old and new pools were 19·5 and 7·4 per cent respectively. In the basal state the rate of thyroglobulin hydrolysis was lower from the old pool but the rate of hormone secretion was similar from both pools. Thyrotrophin (TSH) increased the rate of thyroglobulin hydrolysis and hormone release from both pools by up to four to six times the basal rate, the effect being maximal 2 h after administration of TSH and lasting for 6–8 h. The rate of thyroglobulin hydrolysis after TSH was similar in both pools but the rate of release of labelled iodothyronines was significantly higher from the old pool. These studies have indicated that although hydrolysis of thyroglobulin proceeds faster in the new pool than in the old ('last come, first served' hypothesis) nevertheless there is no difference in the rate of hormone secretion from the two pools, and hydrolysis in both pools is affected by TSH.
Search for other papers by T. H. Jones in
Google Scholar
PubMed
Search for other papers by B. L. Brown in
Google Scholar
PubMed
Search for other papers by P. R. M. Dobson in
Google Scholar
PubMed
Introduction
Intercellular communication is effected through the release and action of substances known as paracrine agents. Recent studies are providing increasing evidence that pituitary hormone secretion is under the control of paracrine as well as hypothalamic factors. The individual cell types within the rat anterior pituitary gland appear to be arranged in specific groups and juxtapositions, and this precise organization of cells provides an anatomical basis for an intercellular control system in the pituitary gland. There is good circumstantial evidence for a variety of paracrine interactions within the anterior pituitary gland, although the exact physiological functions of different proposed paracrine agents have yet to be fully elucidated. Many substances have been shown to affect the release of each of the pituitary hormones directly, and there is evidence that some of these are synthesized and released within the anterior pituitary and may therefore act as paracrine agents. Established and
Search for other papers by T. H. Jones in
Google Scholar
PubMed
Search for other papers by B. L. Brown in
Google Scholar
PubMed
Search for other papers by P. R. M. Dobson in
Google Scholar
PubMed
ABSTRACT
Gonadotrophin-releasing hormone (GnRH) stimulated the accumulation of inositol phosphates and prolactin secretion in anterior pituitary cells from young male rats. Saralasin ([Sar1,Ala8]-angiotensin II; a competitive antagonist of angiotensin II) inhibited the increase in both inositol phosphates and prolactin in a dose-dependent manner. Since angiotensin II has been shown to be a potent stimulus for inositol phosphate accumulation and prolactin secretion in the lactotroph, these findings suggest that angiotensin II acts as a paracrine agent, being released from the gonadotroph in response to GnRH and causing the lactotroph to release prolactin through an effect on phosphoinositide metabolism. The ability of GnRH to promote prolactin release was lost in pituitaries from older rats, and the increase in total inositol phosphate accumulation was less. These findings provide evidence of a physiological role for the presence of the renin–angiotensin system within the pituitary gland.
J. Endocr. (1988) 116, 367–371
Search for other papers by R. S. Sundick in
Google Scholar
PubMed
Search for other papers by D. Herdegen in
Google Scholar
PubMed
Search for other papers by T. R. Brown in
Google Scholar
PubMed
Search for other papers by A. Dhar in
Google Scholar
PubMed
Search for other papers by N. Bagchi in
Google Scholar
PubMed
ABSTRACT
Several studies have shown that iodine plays a role in spontaneous autoimmune thyroiditis in man and other animals. In addition, abnormalities of iodine metabolism have been found in patients with Hashimoto's thyroiditis and in chickens of the obese strain (OS), an animal model of spontaneous autoimmune thyroiditis. We have examined several parameters of iodine metabolism before immune damage in this model and in the related Cornell strain (CS), a strain which develops a late-onset mild thyroiditis, to discover a possible causal relationship between altered iodine metabolism and the initiation of autoimmunity.
Thyroglobulin was purified from individual chicken thyroid glands and analysed for iodine by the ceric sulphate method. Analogous to the thyroglobulin of Hashimoto's patients, the iodine content of OS thyroglobulin (27 atoms/molecule) was lower than that of normal-strain thyroglobulin (46 atoms/molecule) when the chickens were provided with a normal diet. Also, under conditions of TSH suppression, the iodine content of OS thyroglobulin (18 atoms/molecule) was lower than that of CS thyroglobulin (36 atoms/molecule) and of normal-strain thyroglobulin (32 atoms/molecule). In contrast with Hashimoto's patients, however, the OS and CS chickens had practically no inorganic iodide in their thyroid glands; electrophoretic analysis of thyroid homogenates revealed that essentially all (> 99·62%) 125I was organified by 16 h in all strains of birds tested. Despite the relatively poor iodination of thyroglobulin exhibited by OS chickens, they did not iodinate additional 'unique' proteins, when examined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of thyroid proteins labelled with 125I in vivo.
The release of 125I in vivo under conditions of TSH suppression was examined in chicks receiving thyroxine and propylthiouracil. After 14 days both OS and CS chicks showed poorly suppressible release of 85% and 92% respectively, while the normal strain released 33 %. To determine whether the autonomous function of OS and CS thyroid glands was present in a restricted number of follicles or cells or whether it occurred in a majority of cells, autoradiograms of thyroid glands labelled in vivo from TSH-suppressed chickens were examined. Silver grains were present in all cells, indicating that autonomous function was a characteristic of all cells.
These thyroid gland abnormalities are compared with those found in Hashimoto's patients and discussed in the context of their aetiological significance.
Journal of Endocrinology (1991) 128, 239–244
Search for other papers by T. J. BROWN in
Google Scholar
PubMed
Search for other papers by BERYL GINZ in
Google Scholar
PubMed
Search for other papers by CATHERINE M. MILNE in
Google Scholar
PubMed
Search for other papers by R. E. OAKEY in
Google Scholar
PubMed
Slices of human fetal adrenal glands (obtained after abortion at 10–18 weeks of gestation) were superfused sequentially with buffer or with buffer incorporating human ACTH, synthetic ACTH(1–24), human GH, human chorionic gonadotrophin, α-melanocyte stimulating hormone, metenkephalin, ovine prolactin, β-lipotrophic hormone or corticotrophin-like intermediate lobe peptide in concentrations from 10−6 to 10−9 mol/l. Changes in the concentration of dehydroepiandrosterone sulphate (DHAS) in the effluent in response to addition or removal of the polypeptides were measured by radioimmunoassay. Comparison of the quantity of DHAS in the effluent collected during superfusion (5 h) with that present in the tissue initially indicated that synthesis of this conjugated steroid occurred during superfusion.
Increases in the concentration of DHAS in the effluent were provoked by exposure of the tissue to all the polypeptides except corticotrophin-like intermediate lobe peptide.
These effects were unlikely to be non-specific since incorporation of gonadotrophins, albumin or dextran into the superfusate did not stimulate corticosteroid synthesis from viable bovine adrenal tissue.
It was concluded that a number of pituitary polypeptides have the potential to provoke androgen sulphate synthesis by the human fetal gland in early gestation. Consequently there may be no single fetal corticotrophin at this stage and androgen production may be regulated by a number of trophic factors.
Search for other papers by R. J. KEYNES in
Google Scholar
PubMed
Search for other papers by G. W. SMITH in
Google Scholar
PubMed
Search for other papers by J. D. H. SLATER in
Google Scholar
PubMed
Search for other papers by M. M. BROWN in
Google Scholar
PubMed
Search for other papers by S. E. BROWN in
Google Scholar
PubMed
Search for other papers by N. N. PAYNE in
Google Scholar
PubMed
Search for other papers by T. P. JOWETT in
Google Scholar
PubMed
Search for other papers by C. C. MONGE in
Google Scholar
PubMed
Measurements have been made of hormonal changes relevant to salt and water balance during prolonged exposure to hypoxia to improve our understanding of the syndrome of acute mountain sickness. We have attempted to delineate the detailed inter-relationships between the renin–aldosterone and the vasopressin systems by a metabolically controlled study, involving an orthostatic stress (45° head-up tilt) and an injection of a standard dose of ACTH to test adrenal responsiveness. Three Caucasian medical students underwent a 7-day equilibration at 150 m (Lima, Peru), followed by a 6-day sojourn at 4350 m (Cerro de Pasco, Peru) and a final 7 days at 150 m. Measurements were made of sodium and potassium balance, body weight and the 24-h renal excretion of vasopressin, cortisol and aldosterone 18-glucuronide. These variables showed little change, except for that of aldosterone 18-glucuronide, which fell sharply at altitude and rebounded even more sharply on return to sea level. At altitude, basal plasma levels of renin activity and aldosterone fell, and the response to orthostasis was attenuated, but the fall of plasma renin activity, as compared to plasma aldosterone, was delayed; on return to sea level this dissociation was exacerbated with the return of normal renin responsiveness lagging behind that of aldosterone. We suggest that unknown factors which dissociate the orthodox renin–aldosterone relationship, other than the activity of the angiotensin I-converting enzyme, are operative on exposure to hypoxia.
Search for other papers by C. L. van Papendorp in
Google Scholar
PubMed
Search for other papers by I. T. Cameron in
Google Scholar
PubMed
Search for other papers by A. P. Davenport in
Google Scholar
PubMed
Search for other papers by A. King in
Google Scholar
PubMed
Search for other papers by P. J. Barker in
Google Scholar
PubMed
Search for other papers by N. S. Huskisson in
Google Scholar
PubMed
Search for other papers by R. S. Gilmour in
Google Scholar
PubMed
Search for other papers by M. J. Brown in
Google Scholar
PubMed
Search for other papers by S. K. Smith in
Google Scholar
PubMed
ABSTRACT
The aim of this study was to investigate the localization of endothelin-like immunoreactivity (ET-IR) in human placenta, chorion and amnion and to compare the endogenous concentration of immunoreactive endothelin (ET) in these tissues before and after the onset of labour. ET-IR was detected in the endothelium of stem vessels in placental villi, as well as in decidual stromal cells in the basal maternal plate, by immunocytochemistry using a primary polyclonal rabbit antibody. A specific radioimmunoassay was used to detect endogenous concentration of ET in homogenized placental tissues. The endogenous concentration of ET-IR was significantly greater in amnion than in chorion and placenta (amnion 249 ±13 fmol/g; chorion 190 ±11 fmol/g; placenta 169±14 fmol/g; means ± s.e.m.; n = 12; P < 0·01). No significant difference was seen before or after the onset of labour. The detection of ET-IR in placenta, chorion and amnion suggests that the ETs may play a role in the paracrine control of human uterine function.
Journal of Endocrinology (1991) 131, 507–511
Search for other papers by R.G. Forage in
Google Scholar
PubMed
Search for other papers by R.W. Brown in
Google Scholar
PubMed
Search for other papers by K.J. Oliver in
Google Scholar
PubMed
Search for other papers by B.T. Atrache in
Google Scholar
PubMed
Search for other papers by P.L. Devine in
Google Scholar
PubMed
Search for other papers by G.C. Hudson in
Google Scholar
PubMed
Search for other papers by N.H. Goss in
Google Scholar
PubMed
Search for other papers by K.C. Bertram in
Google Scholar
PubMed
Search for other papers by P. Tolstoshev in
Google Scholar
PubMed
Search for other papers by D.M. Robertson in
Google Scholar
PubMed
Search for other papers by D.M. de Kretser in
Google Scholar
PubMed
Search for other papers by B. Doughton in
Google Scholar
PubMed
Search for other papers by H.G. Burger in
Google Scholar
PubMed
Search for other papers by J.K. Findlay in
Google Scholar
PubMed
ABSTRACT
Seven Merino–Border Leicester cross–bred ewes were immunized with a purified fusion protein, produced by recombinant DNA methods, of the a subunit of bovine inhibin. Four animals were immunized with the fusion protein alone and three with a conjugate made by coupling the fusion protein to keyhole limpet haemocyanin (KLH) using glutaraldehyde. Each animal received four injections of the fusion protein over 93 days. The animals were synchronized using progestagen sponges and subjected to laparoscopy for the determination of ovulation rates in two consecutive cycles (days 115 and 135). The immunized animals had overall mean ovulation rates for each cycle of 3.4 and 3.4 which was significantly (P < 0.001) above the rates of 1.1 and 1.4 determined for the controls, which had either received no treatment (n=5) or had been immunized with 300 μg KLH (n=4). Analysis of antisera taken on day 115 showed significant fusion protein antibodies and iodinated inhibin–binding capacity in the test but not control groups. Furthermore, antisera to the fusion protein in four out of seven ewes neutralized the inhibin bioactivity of ovine follicular fluid in an in–vitro bioassay. These data demonstrate that neutralization of inhibin can be effected by immunization with bovine inhibin a subunit and that such immunization results in increased ovulation rates as predicted from the biological role of inhibin as a suppressor of FSH.
